FDA Updates Labels for Two Cholesterol-Lowering Agents FDA Updates Labels for Two Cholesterol-Lowering Agents

New bempedoic acid and bempedoic acid/ezetimibe labels add primary hyperlipidemia and remove the maximally tolerated statin requirement and statement on the effect on mortality.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Source Type: news